Reviva Pharmaceutcls Hldgs I
13F holders, Q1 2026 (March 31)1holders −44
0new positions
21sold out
$0.18avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Reviva Pharmaceutcls Hldgs I in their 13F filings, down 44 from Q4 2025. 0 opened new positions and 21 sold out. The largest holder was IFP Advisors, Inc ($714).
- Company
- Reviva Pharmaceutcls Hldgs I
- CUSIP
- 76152G100
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 21 | $595K |
All 13F filers, Q4 2025 → Q1 2026: 2,116,077 shares sold, net −2,116,077 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | No change | 4,000 | $714 |
"% of holder's portfolio" is REVIVA PHARMACEUTCLS HLDGS I's weight in each manager's 13F, not the share of Reviva Pharmaceutcls Hldgs I the manager owns.